Does semaglutide change hunger and cravings?

The short answer

Two small randomized studies found changes in appetite, cravings and measured food intake with semaglutide. They help explain the experience behind weight-loss numbers, while leaving important questions about everyday eating unanswered.

What happened at a test lunch?

A 20-week trial assigned 72 adults with obesity to weekly semaglutide, increased to 2.4 mg, or placebo. Participants reported less hunger, greater fullness and better control of eating with semaglutide.

At a lunch where participants could choose how much to eat, energy intake was 35% lower with semaglutide than placebo: 1,736 versus 2,676 kilojoules. That was a single test meal—not proof that people ate 35% less every day.

Digestive adverse events occurred more often with semaglutide, including nausea and diarrhea. The small, mostly White study population also limits how broadly its averages can be applied.

What did an earlier study add?

An earlier trial enrolled 30 adults with obesity. Each participant was assigned treatment sequences so they could receive semaglutide and placebo during separate 12-week periods. Twenty-eight completed both periods.

Across the freely chosen lunch, evening meal and snacks on the test day, total energy intake was 24% lower with semaglutide. Participants reported less hunger and fewer cravings. Resting metabolic rate did not differ significantly after adjustment for lean mass.

Two participants withdrew during semaglutide treatment because of digestive adverse events. The authors also noted that weight might not have fully returned to its earlier level between treatment periods, complicating interpretation of weight changes.

The useful takeaway

These studies measured more than the scale: hunger, fullness, cravings and actual food intake. That makes them useful context for understanding how treatment can feel.

They do not establish a universal eating experience or a daily calorie target. Nor should the 35% and 24% figures be ranked against one another: the studies measured different meals, doses and treatment periods.